SUBSCRIBE
SUBSCRIBE

Sangamo Therapeutics, Inc.

NEWS
Technique To Fix DNA Flaws Is Tested
October 19, 2005
 · 
1 min read
Load More
AWARDS
  • 2023 Best Places to Work
JOBS
IN THE PRESS
Biotech Bay
Sangamo Therapeutics Announces Participation at Upcoming Investor Conferences - June 01, 2022
June 1, 2022
 · 
1 min read
Business
Sangamo Therapeutics Reports Recent Business Highlights and First Quarter 2022 Financial Results
May 5, 2022
 · 
13 min read
Biotech Bay
Sangamo Therapeutics to Present Data From Its Next-Generation Technologies at 2022 Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT)
May 2, 2022
 · 
5 min read
Business
Sangamo Therapeutics Announces First Quarter 2022 Conference Call and Webcast
April 28, 2022
 · 
1 min read
Biotech Bay
Sangamo Therapeutics Announces Participation at Upcoming Investor Conferences - Apr 21, 2022
April 21, 2022
 · 
1 min read
Drug Development
Sangamo Therapeutics Announces Dosing of First Patient in Phase 1/2 Clinical Study of Investigational CAR-Treg Cell Therapy TX200 in Kidney Transplantation
March 29, 2022
 · 
6 min read
Biotech Bay
Sangamo Therapeutics Announces Participation at Upcoming Investor Conferences - Feb 28, 2022
February 28, 2022
 · 
1 min read
Business
Sangamo Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Recent Business Highlights
February 24, 2022
 · 
16 min read
Business
Sangamo Therapeutics Announces Fourth Quarter and Full Year 2021 Conference Call and Webcast
February 17, 2022
 · 
1 min read
Drug Development
Sangamo Therapeutics Announces Updated Preliminary Phase 1/2 Data Showing Tolerability and Sustained Elevated α-Gal A Enzyme Activity in Patients With Fabry Disease
February 7, 2022
 · 
8 min read
Load More